ZA200408245B - Dry powder compositions - Google Patents

Dry powder compositions

Info

Publication number: ZA200408245B
Authority: ZA; South Africa
Prior art keywords: dry powder; powder compositions; compositions; dry; powder
Prior art date: 2002-04-13

Application number

ZA200408245A

Other languages

English (en)

Inventor

Roche Trevor Charles

Bulsara Pallav Arvind

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-13

Filing date

2004-10-12

Publication date

2007-03-28

2004-10-12 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2007-03-28 Publication of ZA200408245B publication Critical patent/ZA200408245B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Otolaryngology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ZA200408245A 2002-04-13 2004-10-12 Dry powder compositions ZA200408245B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0208608.0A GB0208608D0 (en)	2002-04-13	2002-04-13	Composition

Publications (1)

Publication Number	Publication Date
ZA200408245B true ZA200408245B (en)	2007-03-28

Family

ID=9934855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200408245A ZA200408245B (en)	2002-04-13	2004-10-12	Dry powder compositions

Country Status (19)

Country	Link
US (1)	US20050244340A1 (is)
EP (1)	EP1494644A1 (is)
JP (1)	JP2005530733A (is)
KR (1)	KR20040099436A (is)
CN (1)	CN1658839A (is)
AR (1)	AR039409A1 (is)
AU (1)	AU2003217073A1 (is)
BR (1)	BR0309114A (is)
CA (1)	CA2481467A1 (is)
GB (1)	GB0208608D0 (is)
IL (1)	IL164420A0 (is)
IS (1)	IS7500A (is)
MX (1)	MXPA04010080A (is)
NO (1)	NO20044497L (is)
PL (1)	PL373294A1 (is)
RU (1)	RU2004130439A (is)
TW (1)	TW200404008A (is)
WO (1)	WO2003088943A1 (is)
ZA (1)	ZA200408245B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003024396A2 (en)	2001-09-17	2003-03-27	Glaxo Group Limited	Dry powder medicament formulations
SE526509C2 (sv) *	2003-06-19	2005-09-27	Microdrug Ag	Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
JP2009513531A (ja) *	2003-07-11	2009-04-02	グラクソグループリミテッド	糖エステルを含む吸入可能医薬製剤
WO2005004845A1 (en) *	2003-07-11	2005-01-20	Glaxo Group Limited	Pharmaceutical formulations comprising magnesium stearate
PE20060272A1 (es)	2004-05-24	2006-05-22	Glaxo Group Ltd	(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
WO2006066907A1 (en) *	2004-12-21	2006-06-29	Glaxo Group Limited	Pharmaceutical formulations
NZ556709A (en) *	2005-02-10	2009-09-25	Glaxo Group Ltd	Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
DE602007013762D1 (de)	2006-08-01	2011-05-19	Glaxo Group Ltd	Pyrazoloä3,4-büpyridinverbindungen und ihre verwendung als pde4-inhibitoren
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
KR20160003183A (ko) *	2013-04-29	2016-01-08	사노피 에스에이	흡입식 약학적 조성물 및 그를 포함하는 흡입기 장치
CN106999599B (zh) *	2014-08-01	2022-09-27	浙江悉娜医药有限责任公司	帕洛诺司琼气雾制剂及其用途
PT109030B (pt) *	2015-12-15	2019-09-25	Hovione Farmaciência, S.A.	Preparação de partículas inaláveis de zafirlucaste
CN110237373B (zh) *	2018-03-08	2023-06-02	润生药业有限公司	一种生产用于联合用药的药物载体的装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR8007911A (pt) *	1979-12-06	1981-06-16	Glaxo Group Ltd	Inalador aperfeicoado
SE448277B (sv) *	1985-04-12	1987-02-09	Draco Ab	Indikeringsanordning vid en doseringsanordning for lekemedel
NZ217006A (en) *	1985-07-30	1989-04-26	Glaxo Group Ltd	Inhaler for finely divided medicament includes plunger to open medicament container
GB9004781D0 (en) *	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
JPH04220268A (ja) *	1990-12-19	1992-08-11	Olympus Optical Co Ltd	バルーンカテーテル
ZA9711732B (en) *	1996-12-31	1998-12-28	Quadrant Holdings Cambridge	Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
JP2002510316A (ja) *	1997-07-03	2002-04-02	クアドラントホールディングスケンブリッジリミテッド	修飾グリコシド、これを含む組成物およびその使用方法
US6352722B1 (en) *	1997-12-23	2002-03-05	Quadrant Holdings Cambridge Limited	Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
EP1283036B2 (de) *	1998-11-13	2020-01-01	Jagotec AG	Multidosis-Trockenpulverinhalator mit Pulverreservoir
GB9916316D0 (en) *	1999-07-12	1999-09-15	Quadrant Holdings Cambridge	Dry powder compositions
GB0015981D0 (en) *	2000-06-29	2000-08-23	Glaxo Group Ltd	Novel process for preparing crystalline particles
GB0020616D0 (en) *	2000-08-21	2000-10-11	Quadrant Holdings Cambridge	Particulates
MXPA03004883A (es) *	2000-12-01	2004-05-04	Battelle Memorial Institute	Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas.
GB0103630D0 (en) *	2001-02-14	2001-03-28	Glaxo Group Ltd	Chemical compounds

2002
- 2002-04-13 GB GBGB0208608.0A patent/GB0208608D0/en not_active Ceased
2003
- 2003-04-10 EP EP03712461A patent/EP1494644A1/en not_active Withdrawn
- 2003-04-10 KR KR10-2004-7016302A patent/KR20040099436A/ko not_active Application Discontinuation
- 2003-04-10 BR BR0309114-7A patent/BR0309114A/pt not_active IP Right Cessation
- 2003-04-10 JP JP2003585695A patent/JP2005530733A/ja active Pending
- 2003-04-10 PL PL03373294A patent/PL373294A1/xx not_active Application Discontinuation
- 2003-04-10 CA CA002481467A patent/CA2481467A1/en not_active Abandoned
- 2003-04-10 US US10/511,042 patent/US20050244340A1/en not_active Abandoned
- 2003-04-10 MX MXPA04010080A patent/MXPA04010080A/es unknown
- 2003-04-10 AU AU2003217073A patent/AU2003217073A1/en not_active Abandoned
- 2003-04-10 WO PCT/GB2003/001542 patent/WO2003088943A1/en active Application Filing
- 2003-04-10 CN CN038137194A patent/CN1658839A/zh active Pending
- 2003-04-10 RU RU2004130439/15A patent/RU2004130439A/ru not_active Application Discontinuation
- 2003-04-11 AR ARP030101280A patent/AR039409A1/es not_active Application Discontinuation
- 2003-04-11 TW TW092108394A patent/TW200404008A/zh unknown
2004
- 2004-10-05 IL IL16442004A patent/IL164420A0/xx unknown
- 2004-10-11 IS IS7500A patent/IS7500A/is unknown
- 2004-10-12 ZA ZA200408245A patent/ZA200408245B/xx unknown
- 2004-10-21 NO NO20044497A patent/NO20044497L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003088943A1 (en)	2003-10-30
EP1494644A1 (en)	2005-01-12
AR039409A1 (es)	2005-02-16
JP2005530733A (ja)	2005-10-13
US20050244340A1 (en)	2005-11-03
TW200404008A (en)	2004-03-16
KR20040099436A (ko)	2004-11-26
RU2004130439A (ru)	2005-06-10
GB0208608D0 (en)	2002-05-22
AU2003217073A1 (en)	2003-11-03
IL164420A0 (en)	2005-12-18
MXPA04010080A (es)	2004-12-13
IS7500A (is)	2004-10-11
CA2481467A1 (en)	2003-10-30
CN1658839A (zh)	2005-08-24
NO20044497L (no)	2004-11-15
PL373294A1 (en)	2005-08-22
BR0309114A (pt)	2005-02-01

Publication	Publication Date	Title
GB0326632D0 (en)	2003-12-17	Dry powder formulations
GB0212062D0 (en)	2002-07-03	Jetable compositions
IL165372A0 (en)	2006-01-15	Immunodenic compositions
EP1487524A4 (en)	2011-01-12	INHALER FOR DRY POWDER
ZA200405383B (en)	2005-10-26	Dry powder inhaler
GB0224415D0 (en)	2002-11-27	Compositions
ZA200408247B (en)	2006-03-29	Dry powder inhalant composition
AU2003218121A8 (en)	2003-09-29	Lotion compositions
GB0214805D0 (en)	2002-08-07	Cosmetic compositions
ZA200408245B (en)	2007-03-28	Dry powder compositions
GB0221894D0 (en)	2002-10-30	Compositions
GB0201163D0 (en)	2002-03-06	Antiperspirant compositions
AU2003269904A8 (en)	2004-01-23	Antigen-polymer compositions
GB0203395D0 (en)	2002-03-27	Compositions
GB0203396D0 (en)	2002-03-27	Compositions
GB0217366D0 (en)	2002-09-04	Compositions
AU2003255721A8 (en)	2004-02-09	Perfume compositions
GB2372518B (en)	2003-04-16	Powder composition
GB2394114B (en)	2005-09-07	Compositions
AU2003216382A8 (en)	2003-09-09	Idothyronine compositions
GB0228540D0 (en)	2003-01-15	Novel compositions
AU2003218497A8 (en)	2003-10-20	Factorviia compositions
GB0201164D0 (en)	2002-03-06	Cosmetic compositions
GB0226159D0 (en)	2002-12-18	Compositions
GB0203356D0 (en)	2002-03-27	Compounds compositions and uses